Novo Nordisk stock last closed at EUR 33.57; Wegovy liver data presented
Published on 10/01/2026 at 23:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk’s last closing price at Lang & Schwarz was EUR 33.57 on September 30, 2026. On October 1, 2026, the company presented new analysis of Wegovy® and liver fat at the European Association for the Study of Diabetes annual meeting in Milan. The findings were reported by GlobeNewswire.
Trading day
Lang & Schwarz recorded a closing price of EUR 33.57 for the previous trading day. The next price is shown from the start of trading by the continuously updated real-time quote of Novo Nordisk stock.
Wegovy liver-fat analysis
Novo Nordisk said its post hoc analysis covered a STEP UP trial subpopulation of 55 adults with obesity without diabetes. Among 26 participants with liver fat above 5% at baseline, 88.5%, or 23 participants, reached levels below 5% by week 72. Mean liver fat declined from 8.8% at baseline to 3.1% at week 72. The company described the analysis as exploratory, and the findings were presented at EASD 2026, according to GlobeNewswire.
